Press Releases
Lilly’s Verzenio for Advanced Breast Cancer Receives Additional FDA...
Eli Lilly and Company announced that the U.S. FDA has approved Verzenioâ„¢ in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy for the...
Press Releases
Novo Nordisk records for regulatory approval of long-acting factor...
Novo Nordisk announced the submission of a Biologics License Applications (BLA) to the US FDA and a Marketing Authorisation Application (MAA) to the European Medicines...
Press Releases
Biogen, AbbVie draw Multiple Sclerosis Drug On Inflammation Reports
RBC analyst Brian Abrahams said the decision will have "zero material impact" on Biogen as Zinbryta was expected to bring in about $400 million in...
Press Releases
Pfizer gets optimistic response from CHMP for its CHEMOTHERAPY...
Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted positive opinions recommending that two Pfizer hematology...
Press Releases
Elsevier collaborates with Beijing University of Chinese Medicine to...
As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business specializing in science and health, announced that it is working...
Press Releases
Enhanced ICP-MS Triple Quadrupole Technology for Ultra-trace Analysis
Semiconductor wafer fabrication plants and ultra-high purity chemical suppliers can now strengthen their monitoring of trace elements within challenging sample matrices with a new triple...
Press Releases
Saneca Pharma renews Pharmascience agreement following successful quality audit
Contract development and manufacturing organisation (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canada’s largest pharmaceutical companies, for the manufacture and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.